Life Tech Rips Promega Bid To Rethink US Damages In IP Row

Law360, New York (January 30, 2018, 9:52 PM EST) -- Life Technologies Corp. on Monday urged the Federal Circuit to uphold its finding that Promega Corp. doesn’t deserve U.S.-specific damages in patent litigation over genetic-testing kits, despite pleas from Promega for a rehearing before the full court.

In November, the circuit court found that Promega waived its right to ask for damages just from U.S. sales when it insisted on a worldwide “all-or-nothing damages strategy.” While Promega denies ever taking such a stance, Life Tech claims Promega was singularly focused on a larger damages pool and...
To view the full article, register now.




Case Information

Case Title

Promega Corp v. Life Tech

Case Number



Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

October 12, 2012

Law Firms


Government Agencies


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.